Target intelligence / Profile preview

Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 3 (ST13P3)

Target
ST13P3
Molecular classification
Other (Processed pseudogene)
01

Overview

ST13P3 is a processed pseudogene located at human chromosome 12q23.3 (genomic coordinates 12:106015897-106017006)[2]. It is named for its sequence similarity to the ST13 gene, which encodes the Hsp70 interacting protein (Hip), a co-chaperone involved in protein folding, but ST13P3 itself does not produce a functional protein and has no established biological function or disease relevance[2][6][7][8]. If you are looking for a true therapeutic target, such as the functional parent gene ST13 ("Suppression of tumorigenicity 13"), this encodes the Hsp70 interacting protein (Hip), which acts as a co-chaperone in protein folding and has been investigated in the context of cancer biology, among other processes[4][9]. However, ST13P3 is a non-functional pseudogene with no current relevance as a therapeutic target.

Other names
FAM10A3FAM10A3PST13, Hsp70 interacting protein pseudogene 3
02

Mechanism of action

None documented for therapeutic agents, as it is not a protein-coding target

03

Biological functions

None established. As a pseudogene, ST13P3 does not encode a functional protein
04

Disease associations

None specifically established for ST13P3. There is no evidence linking this pseudogene to disease biology
05

Safety considerations

None noted, as it is not a therapeutic or diagnostic target
06

Interacting drugs

None. As it does not encode a protein, no drugs interact with ST13P3
07

Biomarkers

None. ST13P3 is not identified as a biomarker for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 3 (ST13P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 3 (ST13P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call